Amsterdam, Netherlands · Founded 2019 · Privately Held (backing)
Developer of a clinical decision support platform designed for blood coagulation management. Hemeo is based in Amsterdam, Netherlands and was founded in 2019. Its last reported valuation was $65.8 million in Oct 2026. It has raised $8.1 million.
Last reported valuation
$65.8M
Oct 2026
Priced at
—
Total raised
$8.1M
Last round
—
Cap table — not yet on record
Hemeo's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Hemeo with a free account
·Watch Hemeo: the Monday email on marks, rounds and moves
